title: What outcome measures are needed to assess gastroesophageal reflux disease in children? what study design is appropriate? what new knowledge is needed?
authors.forename: Benjamin D
authors.initials: BD
authors.lastname: Gold
authors.forename: John
authors.initials: J
authors.lastname: Co
authors.forename: Richard B
authors.initials: RB
authors.lastname: Colletti
authors.forename: Arthur R
authors.initials: AR
authors.lastname: Euler
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Ferris
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Fitzgerald
authors.forename: Alejandro F
authors.initials: AF
authors.lastname: Flores
authors.forename: Hugo
authors.initials: H
authors.lastname: Gallo-Torres
authors.forename: Susan R
authors.initials: SR
authors.lastname: Orenstein
authors.forename: William J
authors.initials: WJ
authors.lastname: Rodriguez
authors.forename: Paul
authors.initials: P
authors.lastname: Willging
mesh_terms: D002648:Child; D002986:Clinical Trials as Topic; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D012449:Safety; D016896:Treatment Outcome